Physiological significance of lysophospholipids that act on the lumen side of mammalian lower digestive tracts

Journal of Health Science

Volumn 57, Issue 2, 2011, Pages 115-128

  Tokumura, Akira ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Gastric ulcer; Lysophosphatidic acid; Lysophospholipid mediator; Mucosa protection

Indexed keywords

ALKALINE PHOSPHATASE; ARACHIDONIC ACID; AUTOTAXIN; GLYCEROLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL; HERBACEOUS AGENT; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 2; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPID; MESSENGER RNA; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; SPHINGOLIPID; SPHINGOMYELIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CHINESE MEDICINE; CHOLERA; COLITIS; COLON CANCER; COLON POLYPOSIS; CROHN DISEASE; DIARRHEA; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM ULCER; DRUG EFFECT; DRUG MECHANISM; DRUG PURIFICATION; DRUG SAFETY; DUODENUM ULCER; HOMEOSTASIS; HOST RESISTANCE; HUMAN; INTESTINE BRUSH BORDER; INTESTINE CANCER; INTESTINE SECRETION; LIPID ABSORPTION; LIPID ANALYSIS; LIPID COMPOSITION; METASTASIS; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHOLIPID BLOOD LEVEL; PHOSPHOLIPID METABOLISM; RADIATION ENTEROPATHY; REVIEW; STOMACH INJURY; STOMACH MUCOSA; STOMACH MUCOSA INJURY; STOMACH PROTECTION; STOMACH ULCER; THERAPY EFFECT; TUMOR PROMOTION; ULCERATIVE COLITIS; WOUND HEALING;

GLYCINE MAX; MAMMALIA; RATTUS;

EID: 79954505527     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.57.115     Document Type: Review

References (112)

1. Turner, J. R. (2009) Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol., 9, 799-809.
2. Rodriguez de Fonseca, F., Navarro, M., Gomez, R., Escuredo, L., Nava, F., Fu, J., Murillo-Rodriguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., Kathuria, S., Gall, C. and Piomelli, D. (2001) An anorexic lipid mediator regulated by feeding. Nature, 414, 209-212.
3. Fu, J., Astarita, G., Gaetani, S., Kim, J., Cravatt, B. F., Mackie, K. and Piomelli, D. (2007) Food intake regulates oleoylethanolamine formation and degradation in the proximal small intestine. J. Biol. Chem., 282, 1518-1528.
4. Sturm, A. and Dignass, A. U. (2002) Modulation of gastrointestinal wound repair and inflammation by phospholipids. Biochim. Biophys. Acta, 1582, 282-288.
5. Tokumura, A. (1995) A family of phospholipid autaocoids: occurrence, metabolism and bioactions. Prog. Lipid Res., 34, 151-184.
6. Noguchi, K., Herr, D., Mutoh, T. and Chun, J. (2009) Lysophosphatidic acid (LPA) and its receptors. Curr. Opin. Pharmacol., 9, 15-23.
7. Okudaira, S., Yukiura, H. and Aoki, J. (2010) Biological roles of lysophosphatidic acid signaling through its production by autotoxin. Biochimie, 92, 698-702.
8. Choi, J. W., Herr, D. R., Noguchi, K., Yung, Y. C., Lee, C. W., Mutoh, T., Lin, M. E., Teo, S. T., Park, K. E., Mosley, A. N. and Chun, J. (2010) LPA receptors: subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol., 50, 157-186.
9. Okumura, S., Baba, H., Kumada, T., Nanmoku, K., Nakajima, H., Nakane, Y., Hioki, K. and Ikenaka, K. (2004) Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells. Cancer Sci., 95, 131-135.
10. Oka, S., Ota, R., Shima, M., Yamashita, A. and Sugiura, T. (2010) GPR35 is a novel lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun., 395, 232-237.
11. Makide, K., Kitamura, H., Sato, Y., Okutani, M. and Aoki, J. (2008) Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol. Prostaglandins Other Lipid Mediat., 89, 135-139.
12. Choi, S., Lee, M., Shiu, A. L., Yo, S. J., Hallden, G. and Aponte, G. W. (2007) GPR93 activation by protein hydrolysate induces CCK transcription and secretion in STC-1 cells. Am. J. Physiol., 292, G1366-G1375.
13. Tomura, H., Mogi, C., Sato, K. and Okajima, F. (2005) Proton-sensing and lysolipid-sensitive Gprotein- coupled receptors: A novel type of multifunctional receptors. Cell. Signal., 17, 1466-1476.
14. Vesper, H., Schmelz, E.-M., Nikolova-Karakashian, M. N., Dillehay, D. L., Lynch, D. V. and Merrill, A. H., Jr. (1999) Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J. Nutr., 129, 1239-1250.
15. Yunoki, K., Ogawa, T., Ono, J., Miyashita, R., Aida, K., Oda, Y. and Ohnishi, M. (2008) Analysis of sphingolipid classes and their contents in meals. Biosci. Biotechnol. Biochem., 72, 223-225.
16. Fischbeck A., Krüger, M., Blaas, N. and Humpf, H.-U. (2009) Analysis of sphingomyelin in meat based on hydrophilic interaction liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (HILIC-HPLC-ESI-MS/MS). J. Agric. Food Chem., 57, 9469-9474.
17. Duan, R. D. (2006) Alkaline sphingomyelinase: An old enzyme with novel implications. Biochim. Biophys. Acta, 1761, 281-291.
18. Duan, R. D. and Nilsson, A. (2009) Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Prog. Lipid Res., 48, 62-72.
19. Schneider, M. (2001) Phospholipids for functional food. Eur. J. Lipid Sci. Technol., 103, 98-101.
20. Rombaut, R., Camp, J. V. and Dewettinck, K. (2005) Analysis of phospho- and sphingolipids in dairy products by new HPLC method. J. Dairy Sci., 88, 482-488.
21. Guo, Z., Vikbjerg, A. F. and Xu, X. (2005) Enzymatic modification of phospholipids for functional applications and human nutrition. Biotechnol. Adv., 23, 203-259.
22. Iqbal, J. and Hussain, M. M. (2009) Intestinal lipid absorption. Am J. Physiol., 296, E1183-E1194.
23. Hundrieser, K. and Clark, R. M. (1988) A method for separation and quantification of phospholipid classes in human milk. J. Dairy Sci., 71, 61-67.
24. Fang, N., Yu, S. and Badger, T. M. (2003) LCMS/ MS analysis of lysophospholipids associated with soy protein isolate. J. Agric. Food Chem., 51, 6676-6682.
25. Tokumura, A., Fukuzawa, K., Akamatsu, Y., Yamada, S., Suzuki, T. and Tsukatani, H. (1978) Identification of vasopressor phospholipid in crude soybean lecithin. Lipids, 13, 468-472.
26. Nakane, S., Tokumura, A., Waku, K. and Sugiura, T. (2001) Hen egg yolk and white contain high amounts of lysophosphatidic acids, growth factorlike lipids: distinct molecular species compositions. Lipids, 36, 413-419.
27. Tanaka, T., Horiuchi, G., Matsuoka, M., Hirano, K., Tokumura, A., Koike, T. and Satouchi, K. (2009) Formation of lysophosphatidic acid, a wound-healing lipid, during digestion of cabbage leaves. Biosci. Biotechnol. Biochem., 73, 1293-1300.
28. Duncan, M., Thomas, A. D., Cluny, N. L., Patel, A., Patel, K. D., Lutz, B., Piomelli, D., Alexander, S. P. and Sharkey, K. A. (2008) Distribution and function of monoacylglycerol lipase in the gastrointestinal tract. Am. J. Physiol., 295, G1255- G1265.
29. Richmond, B. L., Boileau, A. C., Zheng, S., Huggins, K. W., Granholm, N. A., Tso, P. and Hui, D. Y. (2001) Compensatory phospholipid digestion is required for cholesterol absorption in pancreatic phospholipase A2-deficient mice. Gastroenterology, 120, 1193-1202.
30. Takemori, H., Zolotaryov, F. N., Ting, L., Urbain, T., Komatsubara, T., Hatano, O., Okamoto, M. and Tojo, H. (1998) Identification of functional domains of rat intestinal phospholipase B/lipase. Its cDNA cloning, expression, and tissue distribution. J. Biol. Chem., 273, 2222-2231.
31. Huggins, K. W., Boileau, A. C. and Hui, A. D. (2002) Protection against diet-induced obesity and obesity-related insulin resistance in Group 1B PLA2-deficient mice. Am. J. Physiol., 283, E994- E1001.
32. Labonte, E. D., Kirby, R. J., Schildmeyer, N. M., Cannon, A. M., Huggins, K. W. and Hui, D. Y. (2006) Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia. Diabetes, 55, 935-941.
33. Nakano, T., Inoue, I., Katayama, S., Seo, M., Takahashi, S., Hokari, S., Shinozaki, R., Hatayama, K. and Komoda, T. (2009) Lysophosphatidylcholine for efficient intestinal lipid absorption and lipoprotein secretion in Caco-2 cells. J. Clin. Biochem. Nutr., 45, 227-234.
34. Nishimukai, M., Wakisaka, T. and Hara, H. (2003) Ingestion of plasmalogen markedly increased plasmalogen levels of blood plasma in rats. Lipids, 38, 1227-1235.
35. M., Dreier, J. L., Ellis, J.M., Allende, M. L., Kalkofen, D. N., Sanders, K. M., Bielawski, J., Bielawska, A., Hannun, Y. A. and Proia, R. L. (2006) Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids. J. Biol. Chem., 281, 7324-7331.
36. Furuya, H., Ohkawara, S., Nagashima, K., Asanuma, N. and Hino, T. (2008) Dietary sphingomyelin alleviates experimental inflammatory bowel disease in mice. Int. J. Vitam. Nutr. Res., 78, 41-49.
37. Soo, I., Madsen, K. L., Tejpar, Q., Sydora, B. C., Sherbaniuk, R., Cinque, B., Di Marzio, L., Cifone, M. G., Desimone, C. and Fedr'rak, R. N. (2008) VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduced inflammation. Can. J. Gastroenterol., 22, 237-242.
38. Ehehalt, R., Jochims, C., Lehmann, W. D., Erben, G., Staffer, S., Reininger, C. and Stremmel, W. (2004) Evidence of luminal phosphatidylcholine secretion in rat ileum. Biochim. Biophys. Acta, 1482, 63-71.
39. Treede, I., Braun, A., Jeliaskova, P., Giese, T., Fullekrug, J., Griffths, G., Stremmel, R. and Ehehelt, R. (2009) TNF-a-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterology, 9, 53.
40. Langton, S. R. and Cesareo, S. D. (1992) Helicobacter pylori associated phospholipase A2 activity: a factor in peptic ulcer production? J. Clin. Pathol., 45, 221-224.
41. Demirbilek, S., Gürses, I., Sezgin, N., Karaman, A. and Gürbüz, N. (2004) Protective effect of polyunsaturated phosphatidylcholine pretreatment on stress ulcer formation in rats. J. Pediatr. Surg., 39, 57-62.
42. Dunjic, B. S., Axelson, J., Ar'Rajab, A., Larsson, K. and Bengmark, S. (1993) Gastroprotective capability of exogenous phosphatidylcholine in experimentally induced chronic gastric ulcers in rats. Scand. J. Gastroenterol., 28, 89-94.
43. Fabia, R., Ar'Rajab, A.,Willen, R., Andersson, R., Ahren, B., Larsson, K. and Bengmark, S. (1992) Effects of phosphatidylcholines and phosphatidylinositols on acetic acid-induced colitis in the rat. Digestion, 53, 35-44.
44. Dial, E. J., Rooijakkers, S. H. M., Darling, R. L., Romero, J. J. and Lichtenberger, L. M. (2007) Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes. Gastroenterology, 23, 430-436.
45. Mourelle, M., Guarner, F. and Malagelada, J. R. (1996) Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis. Gastroenterology, 110, 1093-1097.
46. Darling, R. L., Romero, J. J., Dial, E. J., Akunda, J. K., Langenbach, R. and Lichtenberger, L. M. (2004) The effects of aspirin on gastric mucosal integrity, surface hydrophobicity and prostaglandin metabolism in cycloxygenase knockout mice. Gastroenterology, 127, 94-104.
47. Ehehalt, R., Wagenblast, J., Erben, G., Lehmann, W. D., Hinz, U., Merle, U. and Stremmel, W. (2004) Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray-tandem mass spectrometry. Scand. J. Gastroenterol., 39, 737-742.
48. Stremmel, W.,Merle, U., Zahn, A., Autschbach, F., Hinz, U. and Ehehalt, R. (2005) Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut, 54, 966-971.
49. Treede, I., Braun, A., Sparla, R., Kühnel, M., Giese, T., Turner, J. R., Anes, E., Kulaksiz, H., Füllekrung, J., Stremmel, R., Griffiths, G. and Ehehalt, R. (2007) Anti-inflammatory effects of phosphatidylcholines. J. Biol. Chem., 282, 27155-27166.
50. Parlesak, A., Schaeckeler, S., Moser, L. and Bode, C. (2007) Conjugated primary bile salts reduce permeability of endotoxin through intestinal epithelial cells and synergize with phosphatidylcholine in intestinal epithelial cells, Crit. Care Med., 35, 2367-2374.
51. Persson, E. M., Nilsson, R. G., Hansson, G. I., Löfgren, L. J., Liback, F., Knutson, L., Abrahamsson, B. and Lennernäs, H. (2006) A clinical single-pass perfusion investigation of the dynamics in vivo secretory response to dietary meal in human proximal small intestine. Pharm. Res., 23, 742-751.
52. Zayat, M., Lichtenberger, L. M. and Dial, E. J. (2008) Pathophysiology of LPS-induced gastrointestinal injury in the rat: role of secretory phospholipase A2. Shock, 30, 206-211.
53. Nakano, T., Inoue, I., Alpers, D. H., Akiba, Y., Katayama, S., Shinozaki, R., Kaunitz, J. D., Ohshima, S., Akita, M., Takahashi, S., Koyama, I., Matsushita, M. and Komoda, T. (2009) Role of lysophosphatidylcholine in brush-border intestinal alkaline phosphatase release and restoration. Am. J. Physiol., 297, G207-G214.
54. Maksem, J., Jacbson, N. and Neiderhiser, D. H. (1984) Lysophosphatidylcholine-induced gastric injury and ulceration in the guinea pig. Am. J. Pathol., 115, 288-295.
55. Neiderhiser, D. H. and Maksem, J. (1987) Gastric mucosal damage induced by combination of ethanol and lysophosphatidylcholine. Dig. Dis. Sci., 32, 628-640.
56. Dial, E. J., Tran, D. M., Romero, J. J., Zayat, M. and Lichtenberger, L. M. (2009) A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury. Shock, 33, 634-638.
57. Kajander, K., Myllyluoma, E., Kyrönpalo, S., Rasmussen, M., Sipponen, P., Mattila, I., Seppönen-Laakso, T., Vapaatalo, H., Oresic, M. and Korpela, R. (2009) Elevated pro-inflammatory and lipotoxic mucosal lipids characterize irritable bowel syndrome. World J. Gastroenterol., 15, 6068-6074.
58. Surrel, F., Jemel, I., Boilard, E., Bollinger, J. G., Payre, C., Mounier, C. M., Talvinen, K. A., Laine, V. J. G., Nevalainen, T. J., Gelb, M. H. and Lambeau, G. (2009) Group X phospholipase A2 stimulates the production of colon cancer cells by producing of various lipid mediators. Mol. Pharmacol., 76, 778-790.
59. Sparkes, B. L., Slone, E. E. A., Roth, M., Welti, R. and Fleming, S. D. (2010) Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemic/reperfusion. Biochim. Biophys. Acta, 1801, 517-525.
60. Tagesson, C., Franzén, L., Dahl, G. and Weström, B. (1985) Lysophosphatidylcholine increases rat ileal permeability to macromolecules. Gut, 26, 369-377.
61. Karlqvist, P. A., Franzen, L., Sjödahl, R. and Tagesson, C. (1986) A study of the permeability of rat stomach to larger molecules. Influence of lysophosphatidylcholine. Acta Chir. Scand, 152, 279-284.
62. Otamiri, T., Sjödahl, R. and Tagesson, C. (1986) Lysophosphatidylcholine potentiates the increase in mucosal permeability after small-intestinal ischemia. Scand. J. Gastroenterol., 21, 1131-1136.
63. Talbot, R. W., Foster, J. R., Hermon-Taylor, J. and Grant, D. A. (1984) Induced mucosal penetration and transfer to portal blood of luminal horseradish peroxidase after exposure of mucosa of guineapig small intestine to ethanol and lysolecithin. Dig. Dis. Sci., 29, 1015-1022.
64. Sawai, T., Lampman, R., Hua, Y., Segura, B., Drongowski, R. A., Coran, A. G. and Harmon, C. M. (2002) Lysophosphatidylcholine alters enterocyte monolayer permeability via a protein kinase C/Ca2+ mechanism. Pediatr. Surg. Int., 18, 591-594.
65. Yan, J. J., Jung, J. S., Lee, J. E., Lee, J., Huh, S. O., Kim, H. S., Jung, K. C., Cho, J. Y., Nam, J. S., Suh, H. W., Kim, Y. H. and Song, D. K. (2004) Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med., 10, 161-167.
66. Ottlecz, A., Romero, J. J. and Lichtenberger, L. M. (2001) Helicobacter infection and phospholipase A2 enzymes: Effect of Helicobacter felis-infection on the expression and activity of sPLA2 enzymes in mouse stomach. Mol. Cell. Biochem., 221, 71-77.
67. Sakata, T., Nakamura, E., Tsuruta, Y., Tamaki, M., Teraoka, H., Tojo, H., Ono, T. and Okamoto, M. (1989) Presence of pancreatic-type phospholipase A2 mRNA in rat gastric mucosa and lung. Biochim. Biophys. Acta, 1009, 124-126.
68. S., Franzen, L., Olaison, G., Smedh, K. and Strom, M. (1991) Phospholipase A2 activity of colonic mucosa in patients with ulcerative colitis. Digestion, 50, 135-141.
69. Minami, T., Tojo, H., Shinomura, Y., Matsuzawa, Y. and Okamoto, M. (1994) Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut, 35, 1593-1598.
70. Watanabe, T., Ohara, S., Ichikawa, T., Saigenji, K. and Hotta, K. (1996) Mechanisms for cytoprotection by vitamin U from ethanol-induced gastric mucosal damage in rats. Dig. Dis. Sci., 41, 49-54.
71. Aoki, J., Inoue, A. and Okudaira, S. (2008) Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta, 1781, 543-548.
72. Mounier, C. M., Wendum, D., Greenspan, E., Flejou, J. F., Rosenberg, D. W. and Lambeau, G. (2008) Distinct expression pattern of the full set of secreted phospholipase A2 in human colorectal adenocarcinomas: sPLA2-III as biomarker candidate. Br. J. Cancer, 98, 587-595.
73. Tokumura, A., Harada, K., Fukuzawa, K. and Ttsukatani, H. (1986) Involvement of lysophospholipase D in the production of lysophosphatidic in rat plasma. Biochim. Biophys Acta, 875, 31-38.
74. Tokumura, A. (2002) Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. Biochim. Biophys. Acta, 1582, 18-25.
75. Tokumura, A. (2004) Metabolic pathways and physiological and pathological significance of lysolipid phosphate mediator. J. Cell. Biochem., 92, 869-881.
76. Nakanaga, K., Hama, K. and Aoki, J. (2010) Autotaxin-an LPA producing enzyme with diverse functions. J. Biochem. (Tokyo), 148, 13-24.
77. Stracke, M. L., Krutzsch, H. C., Unsworth, E. J., Årestad, A., Cioce, V., Schiffmann, E. and Liotta, L. A. (1992) Identification, purification, and partial sequence analysis of autotoxin, a novel motilitystimulating protein. J. Biol. Chem., 267, 2524-2529.
78. Tokumura, A., Majima, E., Kariya, Y., Tominaga, K., Kogure, K., Yasuda, K. and Fukuzawa, K. (2002) Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotoxin, a multifunctional phosphodiesterase. J. Biol. Chem., 277, 39436-39442.
79. Umezu-Goto, M., Kishi, Y., Taira, A., Hama, K., Dohmae, N., Takio, K., Yamori, T., Mills, G. B., Inoue, K., Aoki, J. and Arai, H. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol., 158, 227-233.
80. Khurana, S., Tomar, A., George, S. P., Wang, Y., Siddiqui, R., Guo, H., Tigyi, G. and Mathew, S. (2008) Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia. Exp. Cell Res., 314, 530-542.
81. Ishihara, R., Tatsuta, M., Iishi, H., Baba, M., Uedo, N., Higashino, K., Mukai, M., Ishiguro, S., Kobayashi, S. and Murofushi-Murakami, K. (2004) Attenuation by cyclic phosphatidic acid of peritoneal metastasis of azoxymethane-induced intestinal cancers in Wistar rats. Int. J. Cancer, 110, 188-193.
82. Baker, D. L., Fujiwara, Y., Pigg, K. R., Tsukahara, R., Kobayashi, S., Murofushi, H., Uchiyama, A., Murakami-Murofushi, K., Koh, E., Bandle, R. W., Byun, H. S., Bittman, R., Fan, D., Murph, M. M., Mills, G. B. and Tigyi, G. (2006) Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotoxin and cancer cell invasion and metastasis. J. Biol. Chem., 281, 22786-22793.
83. Funk-Archelta, M. A., Foehr, M. W., Tomei, L. D., Hennebold, K. L. and Bathurst, I. C. (1997) Soy-derived antiapoptotic fraction decreases methotrexate toxicity in the gastrointestinal tract of the rat. Nutr. Cancer, 29, 217-221.
84. Sturm, A., Becker, A., Schulte, K. M., Goebell, H. and Dignass, A. U. (1999) Lysophosphatidic acid modulates intestinal epithelial cell function in vitro by lysophosphatidic acid. Gasteroenterology, 117, 368-377.
85. Sturm, A., Zeeh, J., Sudermann, T., Rath, H., Gerken, G. and Dignass, A. U. (2002) Lisofylline and lysophospholipids ameliorate experimental colitis in rats. Digestion, 66, 23-29.
86. Minami, T., Tojo, H., Zushi, S., Shinomura, Y. and Matsuzawa, Y. (1997). Phospholipase A2 stimulates rat gastric epithelial cell line (RGM-1) migration. Inflamm. Res., 46, 103-107.
87. Bhowmik, A., Paimela, H., Mustonen, H. and Kivilaakso, E. (2002) Roles of cytoskeleton and tyrosine receptor mediated signal transduction in the restitution of isolated guinea-pig gastric mucosa. Scand. J. Gastroenterol., 37, 759-764.
88. M., Horiuchi, G., Ikematsu, N., Tanaka, T., Terao, J., Satouchi, K. and Tokumura, A. (2011) Intragastrically administrated lysophosphatidic acids protect against gastric ulcer in rats under water-immersion restraint stress. Dig. Dis. Sci., DOI 10.1007/S16620-011-19595-0
89. Li, C., Dandridge, K. S., Di, A., Marrs, K. L., Harris, E. L., Roy, K., Jackson, J. S., Makarowa, N. V., Fujiwaha, Y., Farrar, P. L., Nelson, D. J., Tigyi, G. J. and Naren, A. P. (2005) Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interations. J. Exp. Med., 202, 975-986.
90. Singh, A. K., Riederer, B., Krabbenhöft, A., Rausch, B., Bonhagen, J., Lehmann, U., de Jonge, H. R., Donowitz, M., Yun, C., Weinman, E. J., Kocher, O., Hogema, B. M. and Seidler, U. (2009) Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice. J. Clin. Invest., 119, 540-549.
91. + exchanger and fluid absorption via LPA5 and NHERF2. Gastroenterology, 138, 649-658.
92. Singla, A., Dwivedi, A., Saksena, S., Gill, R. K., Alrefai, W. A., Ramaswamy, K. and Dudeja, P. K. (2010) Mechanisms of lysophosphatidic acid (LPA) mediated stimulation of intestinal apical Cl-/OH- exchange. Am. J. Physiol., 298, G182-G189.
93. Cha B., Zhu, X. C., Chen, W., Jones, M., Ryoo, S., Zachos, N. C., Chen, T. E., Lin, R., Sarker, R., Kenworthy, A. K., Tse, M., Kovbasnjuk, O. and Donowitz, M. (2010) NHE3 mobility in brush borders increases upon NHERF2-dependent stimulation by lysophosphatidic acid. J. Cell Sci., 123, 2434-2443.
94. Rusovici, R., Ghaleb, A., Shim, H., Yang, V. W. and Yun, C. C. (2007) Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylated of Bad. Biochim. Biophys. Acta, 1770, 1194-1203.
95. Lin, S., Lee, S. J., Shim, H., Chun, J. and Yun, C. C. (2010) The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine. Am. J. Physiol., 299, G1128-G1138.
96. Deng, W., Shuyu, E., Tsukahara, R., Valentine, W. J., Durgam, G., Gududuru, V., Balazs, L., Manickam, V., Arsura, M., Vanmiddlesworth, L., Johnson, L. R., Parrill, A. L., Miller, D. D. and Tigyi, G. (2007) The lysophosphatidic acid type 2 Receptor is required for protection against radiation-induced intestinal injury. Gastroenterology, 132, 1834-1851.
97. Shida, D., Kitayama, J., Yamaguchi, H., Okaji, Y., Tsuno, N. H., Watanabe, T., Takuwa, Y. and Nagawa, H. (2003) Lysophosphatidic acid (LPA) enhances the metastatic potentials of human colon carcinoma DLD1 cells through LPA1. Cancer Res., 63, 1706-1711.
98. Lin, S., Wang, D., Iyer, S., Ghaleb, A. M., Shim, H., Yang, V. W., Chun, J. and Yun, C. C. (2009) The absence of LPA2 attenuates tumor formation in an experimental model of colitisassociated cancer. Gastroenterology, 136, 1711-1720.
99. Lee, C. W., Rivera, R., Gardell, S., Dubin, A. E. and Chun, J. (2006) GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP; LPA5. J. Biol. Chem., 281, 23589-23597.
100. Kotarsky, K., Boketoft, A., Bristulf, J., Nilsson, N. E., Norberg, A., Hansson, S., Owman, C., Sillard, R., Leeb-Lundberg, L. M. F. and Olde, B. (2006) Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphpcytes. J. Pharmacol. Exp. Ther., 318, 619-628.
101. Lee, M., Choi, S., Halldén, G., Yo, S. J., Schichnes, D. and Aponte, G. W. (2009) P2Y5 is Gai, Ga12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion. Am. J. Physiol., 297, G641- G654.
102. Tatsuta, M., Iishi, H., Baba, M., Uedo, N., Ishihara, R., Higashino, K., Mukai, M. and Ishiguro, S. (2005) Induction by lysophosphatidic acid of peritoneal and pleural metastased of intestinal cancers induced by azoxymethane in Wistar rats. Cancer Lett., 219, 137-145.
103. Shida, D., Watanabe, T., Aoki, J., Hama, K., Kitayama, J., Sonoda, H., Kishi, Y., Yamaguchi, H., Sasaki, S., Sako, A., Konishi, T., Arai, H. and Nagawa, H. (2004) Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab. Invest., 84, 1352-1362.
104. Lee, S. J. and Yun, C. C. (2010) Colorectal cancer cells-Proliferation, survival and invasion by lysophosphatidic acid. Int. J. Biochem. Cell Biol., 42, 1907-1911.
105. Yamashita, H., Kitayama, J., Shida, D., Ishikawa, M., Hama, K., Aoki, J., Arai, H. and Nagawa, H. (2006) Differential expression of lysophosphatidic acid receptor-2 in intestinal and diffuse type gastric cancer. J. Surg. Oncol., 93, 30-35.
106. Kim, M. H., Park, J. S., Chang, H. J., Baek, M. K., Kim, H. R., Shin, B. A., Ahn, B. W. and Jung, Y. D. (2008) Lysophosphatidic acid promotes cell invasion by up-regulation the urokinase-type plasminogen activator in human gastric cancer cells. J. Cell. Biochem., 104, 1102-1112.
107. Thamilselvan, V., Li, W., Sumpio, B. E. and Basson, M. D. (2002) Sphingosine-1-phosphate stimulates human Caco-2 intestinal epithelial proliferation via p38 activation and activates ERK by an independent mechanism. In Vitro Cell. Dev. Biol. Anim., 38, 246-253.
108. Snider, A. J., Kawamori, T., Bradshaw, S. G., Orr, K. A., Gilkeson, G. S., Hannun, Y. A. and Obeid, L. M. (2009) A role for sphingosine kinae 1 in dextran sulfate sodium-induced colitis. FASEB J., 23, 143-152.
109. Greenspon, J., Li, R., Xiao, L., Rao, J. N., Marasa, B. S., Strauch, E. D., Wang, J. Y. and Turner, D. J. (2009) Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway. Dig. Dis. Sci., 54, 499-510.
110. Prestwich, G. D., Gajewiak, J., Zhang, H., Xu, X., Yang, G. and Serban, M. (2008) Phosphataseresistant analogues of lysophosphatidic acid agonists promote healing antagonists and autotoxin inhibitors treat cancer. Biochim. Biophys. Acta, 1781, 588-594.
111. Parrill, A. L. and Baker, D. L. (2008) Autotaxin inhibitions: challenges and progress toward novel anti-cancer agents. Anticancer Agents Med. Chem., 8, 917-923.
112. Ueda, K., Yoshioka, M., Yoshihara, M., Nakao, M., Tanaka, T., Sano, S., Fukuzawa, K. and Tokumura, A. (2010) Evaluation of inhibitory action of flavonols and related substances on lysophospholipase D activity of serum autotoxin by a convenient assay using a chromogenic substrate. J. Agric. Food Chem., 58, 6053-6063.